MDxHealth (MDXH) Invested Capital (2020 - 2026)

MDxHealth has reported Invested Capital for 7 years, with the latest figure at $95.9 million in Q1 2026.

• Quarterly Invested Capital rose 27.31% year-over-year to $95.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $76.0 billion (up 24138.11% YoY) and the FY2025 annual result came in at $153.3 million, up 12.79% from the prior year.
• Invested Capital declined to $95.9 million in Q1 2026 per MDXH's latest filing, from $153.3 million in the prior quarter.
• Over five years, Invested Capital peaked at $75.7 billion in Q2 2025 and troughed at $34.6 million in Q2 2022.
• A 5-year average of $5.1 billion and a median of $51.3 million in 2024 frame the typical range for Invested Capital.
• The sharpest annual moves came in 2023 and 2025: Invested Capital advanced 1.78% in 2023, then soared 147341.14% in 2025.
• Over 5 years, Invested Capital stood at $34.9 million in 2022, then soared by 232.9% to $116.2 million in 2023, then advanced by 16.94% to $135.9 million in 2024, then rose by 12.79% to $153.3 million in 2025, then plunged by 37.41% to $95.9 million in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $95.9 million, $153.3 million, and $75.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.